U.S. flag

An official website of the United States government

NM_000128.4(F11):c.981C>A (p.Cys327Ter) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 22, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003555168.2

Allele description [Variation Report for NM_000128.4(F11):c.981C>A (p.Cys327Ter)]

NM_000128.4(F11):c.981C>A (p.Cys327Ter)

Gene:
F11:coagulation factor XI [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
4q35.2
Genomic location:
Preferred name:
NM_000128.4(F11):c.981C>A (p.Cys327Ter)
HGVS:
  • NC_000004.12:g.186280338C>A
  • NG_008051.1:g.19375C>A
  • NM_000128.4:c.981C>AMANE SELECT
  • NP_000119.1:p.Cys327Ter
  • NP_000119.1:p.Cys327Ter
  • LRG_583t1:c.981C>A
  • LRG_583:g.19375C>A
  • LRG_583p1:p.Cys327Ter
  • NC_000004.11:g.187201492C>A
  • NM_000128.3:c.981C>A
Protein change:
C327*
Molecular consequence:
  • NM_000128.4:c.981C>A - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV004292790Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))		Pathogenic
(Dec 22, 2023) 		germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Congenital factor XI deficiency: an update.

Duga S, Salomon O.

Semin Thromb Hemost. 2013 Sep;39(6):621-31. doi: 10.1055/s-0033-1353420. Epub 2013 Aug 8. Review.

PubMed [citation]
PMID:
23929304

Severe factor XI deficiency in the Abruzzo region of Italy is associated to different FXI gene mutations.

Castaman G, Giacomelli SH, Dragani A, Iuliani O, Duga S, Rodeghiero F.

Haematologica. 2008 Jun;93(6):957-8. doi: 10.3324/haematol.12540. No abstract available.

PubMed [citation]
PMID:
18515884
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004292790.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change creates a premature translational stop signal (p.Cys327*) in the F11 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in F11 are known to be pathogenic (PMID: 23929304). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with clinical features of FXI deficiency (PMID: 18515884). This variant is also known as C309X. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024